STAT November 13, 2024
Elaine Chen

Good morning, lots of news this morning that we’ll get straight into.

Califf: ‘We’ll see what happens’ under Trump

At a cancer research conference yesterday, FDA Commissioner Robert Califf said he’s “disappointed” about the election’s outcome and suggested he’s unsure about the future of the agency under the incoming Trump administration.

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s hostility to civil servants. Trump has said he plans to give Kennedy, leader of the “Make America Healthy Again” movement, power over health care policy in his administration.

“I’m biased, but I feel like the FDA is at peak performance right now and we’ll just see what happens as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma / Biotech, Trends
Related Articles:
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article